
Announcing the 2025 Eczema Society of Canada Research Grant Recipient
ESC awards research grant to University of Toronto researchers Eczema Society of Canada (ESC) is delighted to announce the winner of the 2025 Competitive Research

ESC awards research grant to University of Toronto researchers Eczema Society of Canada (ESC) is delighted to announce the winner of the 2025 Competitive Research

2022 ESC competitive research grant winner publishes research results ESC is proud to share that Dr. Yuka Asai, MD, PhD, FRCPC, has published her findings

ESC awards research grant to University of British Columbia researchers Eczema Society of Canada (ESC) is delighted to announce the winners of the 2024 Competitive

About this publication This publication aims to review what patients are describing related to topical corticosteroids and eczema. We hope the content shared here will

Congratulations to the Recipients of the 2023 ESC Research Grants Eczema Society of Canada (ESC) is delighted to announce the two winners of the competitive

Many people who suffer from AD are familiar with the term flare – an increase in the signs and symptoms, but agreeing to the definition of a flare is another story.

Learn more about HOME’s initiative to establish a universal core outcome set, ensuring clinical trials focus on measures that truly matter to patients.

Learn how new therapies and ongoing research are shaping the future of eczema care.

ESC is proud to partner with the research organization Skin Investigation Network (SkIN) of Canada to help move Canadian research on atopic dermatitis forward. Recently,

2022 Research Grant Program recipients Eczema Society of Canada (ESC) is pleased to announce two recipients of the 2022 competitive Research Grant Program (RGP) for

Apply now for ESC’s 2023 Research Grant program ESC is accepting new applications for the 2023 Research Grant program! The ESC Research Grant program is

Processes and new advancements in atopic dermatitis treatments There have been many advancements in research and treatments for atopic dermatitis (AD) in recent years, and